We speak to the director of the Wake Forest Institute of Regenerative Medicine – a research organisation with a clear focus on commercialisation.
Just on...
Omega Therapeutics secures $85m to carry out clinical trials into epigenetic treatments for five key disease areas – and potentially for Covid-19.
While you might...
Company spawned by London start-up generator targets middle-aged recreational athletes with exoskeleton leggings powered by soft robotics.
Back in November, we brought you the story...
SENS Research Foundation's Aubrey de Grey on increasing investor appetites and the elephant in the Longevity room.
Continuing our series of interviews with our Advisory Panel...
University of Exeter spinout raising seed investment as it targets aging aesthetics and age-related disease with ground-breaking rejuvenation technology.
Deep in the labs at the...
Professor João Pedro de Magalhães on different areas of Longevity.
Continuing our series of interviews with our Advisory Panel members, we caught up with João Pedro...
Tom Britton joins Advisory Panel as plans for Longevity equity funding platform take another step forward.
Longevity.Technology: Just last month we announced the formation of...
LyGenesis' Michael Hufford talks Longevity research programmes and investment.
Kicking off a series of interviews with our Advisory Panel members, we chatted to Michael Hufford,...
Co-founder of Longevity-focused investment firm shows you can target aging AND appeal to biotech investors.
Founded in 2016, Berlin and Boston-based Apollo already boasts an...
Professor Richard Faragher asks why developments in aging research have been largely ignored in the global response to the COVID-19 pandemic.
With the world currently...
Insilico announces Deep Longevity, a spin-out that will collaborate with Human Longevity Inc. to deploy an extensive range of AI-powered aging clocks.
Insilico Medicine has...
We talk with VC investor Forte Ventures about its first foray into AgeTech, COVID-19 and the Longevity investment opportunity.
Longevity agetech company K4Connect has announced...
There is rapidly-increasing activity in both the research and the investment communities that focus on Longevity; this survey gets into the details.
The global Longevity...
Personalised gut health testing market is hotting-up and could revolutionise anti-aging intervention tracking.
San Diego-headquartered microbiome health company Sun Genomics is set to build on...
Our current survey is throwing-up some great data. Here's a taster of what we've learned from Longevity investors.
We're currently running our surveys for Longevity...
Calling all Longevity investors, founders, c-suite and university spin-outs.
Longevity is hotting-up and we're asking for 3 minutes of your time to help us help...
Life Biosciences' new fundraising push seeks answers to big aging questions, but won't be drawn on its strategy.
Harvard scientist David Sinclair is one of...
Some news of our own: we're expanding our Board and funding for growth.
Health and med-tech leader, George Sutherland, enters the Longevity industry to support...
We take a trip down Lifespan.io's Rejuvenation Roadmap – and it's a journey towards Longevity progress.
Lifespan.io is a US-based non-profit organisation that seeks to...
Non-invasive therapy that comes in a bottle could be the Longevity crème de la crème.
Therapeutic substances like arnica, turmeric and witch hazel have been...
